|
HS Code |
383776 |
| Product Name | Ceftazidime Sodium Carbonate |
| Chemical Formula | C22H22N6O7S2 · Na2CO3 |
| Appearance | White to off-white powder |
| Molecular Weight | 636.6 g/mol (Ceftazidime) + 105.99 g/mol (Sodium carbonate) |
| Solubility | Freely soluble in water |
| Pharmaceutical Class | Third-generation cephalosporin antibiotic |
| Storage Temperature | 2°C to 25°C |
| Route Of Administration | Intravenous or intramuscular injection |
| Stability | Stable when stored in original packaging, away from moisture and light |
| Ph Of Solution | 5.0 to 7.5 |
| Mechanism Of Action | Inhibits bacterial cell wall synthesis |
| Intended Use | Treatment of bacterial infections, especially Gram-negative bacteria |
| Packaging | Vials for injection |
| Cas Number | 78439-06-2 (Ceftazidime), 497-19-8 (Sodium carbonate) |
| Colour Reconstitution | Clear to pale yellow solution |
As an accredited Ceftazidime Sodium Carbonate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging contains 10 vials of Ceftazidime Sodium Carbonate, each vial holding 1 gram, sealed in a sterile, labeled box. |
| Shipping | Ceftazidime Sodium Carbonate should be shipped in tightly sealed containers, protected from light and moisture. It must be transported at controlled room temperature, avoiding excessive heat. Ensure proper labeling as a pharmaceutical or chemical substance, and follow all applicable regulations for the safe handling and transport of medicinal products. |
| Storage | Ceftazidime Sodium Carbonate should be stored in a tightly closed container, protected from light and moisture. Keep it at a temperature between 2°C and 8°C (36°F–46°F) and avoid freezing. Store in a dry, well-ventilated area, away from incompatible substances. Proper storage ensures stability and potency, reducing the risk of contamination or degradation of the chemical. |
|
Purity 98%: Ceftazidime Sodium Carbonate with a purity of 98% is used in injectable antibiotic formulations, where it ensures consistent antimicrobial efficacy. Molecular Weight 636.56 g/mol: Ceftazidime Sodium Carbonate at a molecular weight of 636.56 g/mol is used in hospital compounding pharmacies, where it provides accurate dosing and predictable pharmacokinetics. pH Stability 5.0–7.5: Ceftazidime Sodium Carbonate with pH stability between 5.0 and 7.5 is used in intravenous infusion solutions, where it guarantees solution stability during storage and use. Low Endotoxin Level: Ceftazidime Sodium Carbonate with low endotoxin levels is used in critical care infection control, where it reduces the risk of pyrogenic reactions in patients. Particle Size <10 µm: Ceftazidime Sodium Carbonate with a particle size of less than 10 µm is used in reconstitutable powder formulations, where it enables rapid and complete dissolution. Water Solubility >100 mg/mL: Ceftazidime Sodium Carbonate with water solubility greater than 100 mg/mL is used for high-concentration dose preparations, where it allows for flexible administration volumes. Stability Temperature 2–8°C: Ceftazidime Sodium Carbonate with a stability temperature range of 2–8°C is used in refrigerated pharmaceutical storage, where it maintains potency over extended periods. |
Competitive Ceftazidime Sodium Carbonate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
The fast-evolving world of health care throws up new challenges every day. Resistance patterns change. Infections grow harder to treat. Among the tools doctors rely on, effective antibiotics still make a world of difference. Ceftazidime Sodium Carbonate stands out for those facing tough gram-negative suspects, especially Pseudomonas aeruginosa. Its name might feel a bit of a mouthful, but clinicians and pharmacists know it for what it does best — stepping in where many older drugs fall short.
This product appears in many hospitals as a white to off-white powder, carefully packed and measured. The packaging often lists the sodium carbonate component not to confuse, but to clarify it sits blended for reasons beyond mere technicality. Sodium carbonate isn’t just an additive. It adjusts the pH, making reconstitution easier, supporting drug stability and patient safety. Some manufacturers lean toward glass vials, sealed for freshness and sterility, from batches subjected to a battery of quality control checks.
Doctors often request the 1g or 2g vials—those are the mainstays for adults. Pediatric wards sometimes call for different preparations, but the bulk of daily use comes from these sizes. The powder dissolves in prescribed diluents—usually sterile water, sometimes normal saline—mixing into a clear solution for IV or IM injection. This flexibility makes it possible to use in inpatient and outpatient settings, wherever difficult infections hang around.
Some products come as single-dose vials, others as multi-use, depending on institutional preference and safety protocols. Regulatory requirements push for clear labelling and stringent sterility, protecting both the nurse who draws up the dose and the patient on the receiving end. For many health care workers, the reliability of supply and predictability of product specs makes a big difference. Nobody working a midnight shift wants to discover that vials from different sources dissolve at different rates or require adjusting the dilution each time — consistency matters, not just for ease, but for patient safety.
Behind the pharmacy counter, there’s more to this product than meets the eye. By combining ceftazidime with sodium carbonate, the drug travels smoothly into solution. Ceftazidime alone suffers from instability; the sodium carbonate buffer helps it stand up to the rigors of real-world storage and reconstitution. Mistakes in preparation in the hospital can lead to clogs in IV lines or, worse, underdosed patients.
Ceftazidime’s action shows itself particularly in combating infections where other antibiotics have lost their edge. It targets gram-negative bacilli including Enterobacteriaceae and non-fermenters. If you’re dealing with a ventilator-associated pneumonia or sepsis in a high-acuity ICU, there’s a strong chance you might reach for this powder. Adding sodium carbonate isn’t just a technical tweak — it tweaks the chemistry to deliver a reliably potent solution, every time.
Some people wonder, why not just use plain ceftazidime without the wordy buffer? The answer starts with stability. Ceftazidime powders left unbuffered break down too fast, especially under the heat and pressure found in real-world transports and pharmacies. Sodium carbonate shifts the pH, blocks certain degradation pathways, and helps avoid issues with clumping or incomplete dissolution.
There are other cephalosporins on the shelf—cefepime, cefotaxime, ceftriaxone—but ceftazidime takes a firm stand against those hard-to-clear pseudomonas and acinetobacter bugs, which have evolved to slip past older agents. Doctors tracking local resistance patterns know when a ward starts showing higher minimum inhibitory concentrations for cefepime, switching to ceftazidime can save lives. Other formulations, like ceftazidime/avibactam, add beta-lactamase inhibitors to tackle superbugs, but the base reliability of ceftazidime sodium carbonate keeps it relevant for straightforward, sensitive cases.
Clinical pharmacists sweat the details. Dosing charts hang behind ward counters for a reason: the right dose, mixed the right way, with minimal waste every day. For adults, the most common dose comes in at 1g every 8-12 hours. Neonates and children get weight-based doses, double-checked and recounted. In every case, the powder must dissolve completely to avoid line blockages or dosing errors. Fresher solutions give the best results; nurses reconstitute just before use where possible.
Antimicrobial stewardship teams keep a sharp eye on ceftazidime use, balancing its broad-spectrum punch with a watchful stewardship eye. Many hospitals restrict these drugs, making them available only on infectious disease approval. Using ceftazidime sodium carbonate when it isn’t strictly needed risks jumping the gun, possibly helping breed resistance down the line. Its biggest strength — powerful effect against dangerous bacteria — can soon become a liability if overused or used as a first-line agent in the wrong cases.
Quality assurance can’t be taken for granted — not after seeing vials from a batch come in clumped or difficult to dissolve. Frustrated nurses, patients waiting extra minutes, a spike in complaints on the pharmacy line — all stemming from overlooked production slip-ups. The brands that win repeat business tend to deliver not just on price but on reliability. You notice the difference when handling powder that dissolves readily, gives a clear solution, and doesn’t throw the team into a muddle chasing new preparation instructions per lot.
Having worked with ceftazidime sodium carbonate through dozens of supply cycles in tertiary care, it feels obvious how much trust is built on basics. A clean, stable powder and precise labelling take stress out of busy shifts. Batch consistency means no surprises. Dosing accuracy keeps the focus where it belongs: on the patient’s response and not on battling mysterious technical hiccups.
Those used to ceftazidime sodium carbonate rarely bother switching back to plain ceftazidime once they’ve seen the headaches of partial solubility and unpredictable stability fade away. In centers with higher ambient temperatures or inconsistent cold-chain logistics, buffered ceftazidime pays everyday dividends. Repeated audits bear this out. Pharmacists and infection control teams note fewer requests for clarifications, less wastage, and fewer delays in administration.
Even the finer points—like whether a reconstituted solution stays clear over the infusion window, or stays within safe pH limits—can make a difference. Some competitors market dual-chamber bags or ready-to-use syringes, but these often cost much more and still need to prove they outdo traditional powder-vial options. Feedback from frontline clinicians most often highlights how the sodium carbonate buffer streamlines work and maintains confidence in the final solution.
Patients who need ceftazidime often come with fragile health: transplants, cancer, critical sepsis, neonatal sepsis. Small errors unravel quickly. Buffered powder lends stability to the dose, reducing the chance of precipitation or partial dissolution. Nurses and pharmacists on the sharp end of things don’t want to play “hard clumps in the vial” during crunch time. Adverse reactions from unstable solutions can mean everything from minor infusion site discomfort to treatment delays in people who can’t afford to wait.
Direct experience reinforces the importance of the manufacturing chain. Lapses at one point — supply chain contamination, mislabelling, inadequate buffer amounts — travel down the line to bedside harm. Hospitals that keep a tight feedback loop with suppliers have reported fewer incidents, highlighting how reliable sourcing underpins safe care. Some have even tied shorter average lengths of stay to more accurate and regular dosing, an indirect but telling mark of a well-chosen product.
Reliable antibiotics are lifelines, but global supply interruptions have become all too common. Stories pop up of hospitals running short even on basic drugs, not to mention harder-to-source ceftazidime with sodium carbonate. The sourcing journey often spans several countries, moving from factory, into warehouses, onto hospital loading docks, and finally to patient bedsides. Vulnerabilities in any step threaten treatment plans for some of society’s sickest individuals.
Some governments and health systems hedge by keeping essential drug lists and contracting with backup suppliers. Still, the bottleneck isn’t always obvious until it bites. It takes flexibility and coordination to navigate recalled lots or inventory shocks. Hospital pharmacists may shift buying patterns, crafting emergency ordering plans. Regional distribution hubs can help, but only if there is broad communication and an industry-wide focus on maintaining high standards throughout the supply chain.
Behind every vial lies a story — burn victims fighting off hospital-acquired pneumonia, neonates rescued from overwhelming sepsis, transplant recipients given a fresh shot against complicated infections. From the outside, the white powder may look innocuous. Watching a patient turn the corner, fevers break, organ function recover, gives you a firsthand appreciation for what the right drug, in the right form, really delivers.
Outcomes link directly to consistent, timely administration. Delays from poor dissolution, confusion over specifications, or incomplete dosing add unnecessary risk. The best ceftazidime sodium carbonate products quietly serve their purpose, slotting into hospital workflows with minimal disruption. They provide reassurance for families and clinicians alike. For every high-profile “miracle cure” story, there are thousands of unsung recoveries where this medication played a part.
Tough antibiotics like this demand equal parts respect and caution. Overuse drives resistance, shrinking the pool of effective options. National and local stewardship programs urge clinicians to pair broad-spectrum agents with precise diagnosis and careful documentation. For pharmaceuticals like ceftazidime sodium carbonate, clear usage guidelines keep misuse in check.
Daily practice involves collaboration: ID physicians, pharmacists, nurses, microbiologists. Chart reviews, culture results, and patient updates guide every decision. Using ceftazidime in ways that limit selection pressure—targeting documented infections or waiting for cultures—offers a sustainable model. Avoiding knee-jerk “just in case” prescribing extends the usefulness of crucial tools, benefitting everyone who might one day rely on robust, accessible antibiotics.
The future for ceftazidime sodium carbonate holds promise, but challenges remain. Some development teams pursue pre-filled syringes, hoping to eliminate reconstitution errors. Others look to blend digital technology, supporting dosing and tracking with barcoded vials or automated delivery systems. But simplicity and reliability still carry the day in most critical-care environments. Nurses and pharmacists don’t need new complications; they ask for rock-solid basics.
More research keeps surfacing around real-life drug stability and the influence of newer packaging. Field studies with serious infection patients add layers of insight. Comparing ceftazidime sodium carbonate use across regions and health settings, many teams see the same themes emerge: doses given on schedule, solutions prepared with fewer hiccups, and patient recovery tied closely to routine, repeatable practice.
My own time spent supporting doctors and pharmacists through tough outbreaks has shown a few truths. Reliable products earn loyalty the hard way — by weathering years of daily challenges, not just launching with a splash. Small differences in formulation build up to major differences in daily safety and patient ease. Sodium carbonate doesn’t just buffer the powder; it buffers the stress and uncertainty of frontline teams fighting high-stakes infections.
Talking with colleagues, pharmacists repeatedly voice the same priority: having confidence that each vial will dissolve as expected, stay potent as needed, and fit seamlessly into trusted dosing routines. That confidence isn’t born from abstract technical claims, but from vials handled, doses prepared, and patients cared for. Manufacturers who pay close attention to formulation, packaging, and quality control make a quiet but profound impact on recovery stories in wards everywhere.
Ceftazidime sodium carbonate’s importance may not grab headlines, but those delivering critical care recognize its place in the bigger picture. It isn’t just about ticking boxes or matching guidelines. It’s about ensuring that, when the stakes run high, every dose counts — and every patient has the best shot possible at recovery, comfort, and a tomorrow free from hospital walls.